Free Daily Podcast Summary
Oncology Today with Dr Neil Love: Daily Summaries Delivered
by Dr. Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 4 days ago58 min
Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Featuring perspectives from Dr Gottfried E Konecny and Dr Brian M Slomovitz, including the following topics:Introduction Preventing Ovarian Cancer Endometrial Cancer Ovarian Cancer Cervical Cancer CME information and select publications
- 5 days ago25 min
Metastatic Bladder Cancer — Rapid Case Review Issue 8
Featuring perspectives from Dr Alexandra Drakaki, including the following topics:Case: A man in his late 70s with diabetes and metastatic bladder cancer achieves radiographic response with enfortumab vedotin (EV) and pembrolizumab but develops uncontrolled hyperglycemia Case: A man in his early 70s with muscle-invasive bladder cancer receives adjuvant nivolumab and experiences metastatic progression after 9 cycles of therapy Case: A woman in her early 70s with Lynch syndrome and metastatic upper tract bladder cancer receives EV/pembrolizumab and develops myasthenia gravis Case: A woman in her late 40s with FGFR3 mutant metastatic bladder cancer receives erdafitinib and experiences rising serum phosphate levels CME information and select publications
- 5 days ago36 min
Metastatic Bladder Cancer — Rapid Case Review Issue 7
Featuring perspectives from Dr Alexandra Drakaki, including the following topics:Case: A man in his early 80s with bladder cancer and metastatic progression in the viscera and lymph nodes receives enfortumab vedotin (EV) with pembrolizumab — Part 1 Case: A man in his early 80s with metastatic bladder cancer achieves a complete response with EV/pembrolizumab therapy but develops gastrointestinal toxicity — Part 2 Case: A man in his early 50s with metastatic bladder cancer receives second-line EV monotherapy intermittently Case: A woman in her mid 60s with bladder cancer and a history of rheumatoid arthritis develops oligometastatic progression in the lung and receives EV monotherapy Case: A man in his mid 80s with HER2-positive (IHC 3+) metastatic bladder cancer receives trastuzumab deruxtecan and develops ground glass opacities in his lungs concerning for pneumonitis CME information and select publications
- 6 days ago1h 29m
Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Featuring perspectives from Dr Aditya Bardia, Dr Kevin Kalinsky and Dr Joyce O'Shaughnessy, including the following topics:Introduction Hormone Receptor-Positive Breast Cancer — Dr Kalinsky HER2-Positive Breast Cancer — Dr Bardia Triple-Negative Breast Cancer — Dr O'Shaughnessy CME information and select publications
- 1 weeks ago26 min
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2
Featuring perspectives from Dr Rachel N Grisham, including the following topics:Case: A woman in her early 40s with recurrent low-grade serous ovarian cancer (LGSOC) and prior treatment with a MEK inhibitor receives avutometinib/defactinib on the RAMP 301 trial Case: A woman in her early 70s with recurrent KRAS-mutated LGSOC receives avutometinib/defactinib and develops muscle weakness Case: A woman in her late 70s with KRAS-mutated recurrent LGSOC develops congestive heart failure on trametinib and then receives avutometinib/defactinib Case: A woman in her mid 60s with recurrent BRAF V600E LGSOC has concerns about side effects and receives single-agent dabrafenib CME information and select publications
- 1 weeks ago28 min
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1
Featuring perspectives from Dr Rachel N Grisham, including the following topics:Mechanism, clinical evidence and practical use of avutometinib with defactinib for recurrent low-grade serous ovarian cancer (LGSOC) A Phase III trial of letrozole alone as front-line treatment for LGSOC Current and future role of avutometinib with defactinib for LGSOC A Phase II/III trial of trametinib for recurrent LGSOC: Biomarker analyses and clinical implications CME information and select publications
- 1 weeks ago59 min
Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus
Featuring an interview with Prof Andreas Hochhaus, including the following topics:Biology of chronic myeloid leukemia (CML) and rationale for current therapeutic approaches; importance of cytogenetic testing Mechanistic differences among first-generation tyrosine kinase inhibitors (TKIs), second-generation TKIs and asciminib Potential mechanisms of adverse events documented with TKIs Recent survey of patients with CML regarding goals of therapy and clinical implications; considerations for discontinuation of therapy Comparative tolerability of asciminib and other agents used to manage CML; promoting adherence to treatment plans for patients Comparative efficacy of asciminib and other agents used to treat CML Potential areas for improvement in community oncology practice patterns; family planning in the context of CML treatment Practical care strategies for CML patients; future developments CME information and select publications
- 1 weeks ago20 min
Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Featuring perspectives from Dr Floor J Backes, Dr Matthew A Powell and Dr Ritu Salani, moderated by Dr Salani, including the following topics:Case: A woman in her late 60s with recurrence of metastatic estrogen receptor-positive endometrial cancer enrolls in a trial of CDK4/6 inhibition with an aromatase inhibitor 1 year into maintenance dostarlimab after carboplatin/paclitaxel/dostarlimab and has no evidence of disease 3 years later Adding a PARP inhibitor to immunotherapy and chemotherapy: The RUBY Part 2 and DUO-E trials CME information and select publications
Get Oncology Today with Dr Neil Love summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.
The Dr. Gabrielle Lyon Show
Discusses health, longevity, and mental resilience through science-based conversations with medical and wellness experts.
Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.
Plenary Session
A medical oncologist discusses cancer care, health policy, and evidence-based medicine.
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+
A nurse practitioner shares science-based strategies for managing midlife hormones, menopause, and women's health.
The Clinical Problem Solvers
Experts discuss diagnostic reasoning in clinical medicine.
You Are Not Broken
Explores sex, hormones, and midlife for women with science, humor, and candid conversations about body and mind reconnection.
Health Discovered
Doctors explore surprising stories to uncover insights about health and well-being.
Paul Saladino MD podcast
A physician explores the root causes of chronic disease and optimal health through science and personal experimentation.
Treated with Dr. Sara Szal
Dr. Sara Szal explores holistic health solutions through conversations with experts and patients seeking mind, body, and soul healing.
This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.
About Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Oncology Today with Dr Neil Love in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Oncology Today with Dr Neil Love daily summary?
It's a free AI-powered email that summarizes new episodes of Oncology Today with Dr Neil Love as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Oncology Today with Dr Neil Love podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Oncology Today with Dr Neil Love product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Dr. Neil Love.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Oncology Today with Dr Neil Love release new episodes?
Oncology Today with Dr Neil Love publishes daily. Our AI generates a summary within hours of each new episode.
What topics does Oncology Today with Dr Neil Love cover?
Oncology Today with Dr Neil Love covers topics including Science, Education, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Oncology Today with Dr Neil Love summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.